Document is current
Any future updates will be listed below
-
Authors
,
Hoffmann, M. https://orcid.org/0000-0003-1668-4294
Jeitziner, M.-M.
Riedl, R.
Eller, P. https://orcid.org/0000-0001-5537-3646
Amrein, K. https://orcid.org/0000-0003-0915-085X
-
Funding
Funding for this research was provided by:
ÖGIAIN
- License Information
-
More Information
Article History
Accepted: 3 March 2020
First Online: 18 March 2020
Compliance with ethical standard
:
: M–M. Jeitziner reports grants (full departmental disclosure) from Orion Pharma, Abbott Nutrition International, B. Braun Medical AG, CSEM AG, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd, Maquet Critical Care AB, Omnicare Clinical Research AG, Nestle, Pierre Fabre Pharma AG, Pfizer, Bard Medica S.A., Abbott AG, Anandic Medical Systems, Pan Gas AG Healthcare, Bracco, Hamilton Medical AG, Fresenius Kabi, Getinge Group Maquet AG, Dräger AG, Teleflex Medical GmbH, Glaxo Smith Kline, Merck Sharp and Dohme AG, Eli Lilly and Company, Baxter, Astellas, Astra Zeneca, CSL Behring, Novartis, Covidien, Philips Medical, Phagenesis Ltd, Prolong Pharmaceuticals and Nycomed outside the submitted work. The money went into departmental funds. No personal financial gain applied. All other authors declare that they have no competing interests.
